Abstract:Objective: Recurrent stroke is common with no cure. Systemic interleukin-10 (IL-10) has cytoprotective effects for stroke but with significant side effect. Forced transduction of IL-10 gene in susceptible arteries achieved during interventional treatment management of the first stroke may increase local instead of systemic IL-10 in front and decrease brain damage of recurrent stroke. Methods: Recombinant adeno-associated viral vector 1 encoding rat IL-10 (rAAV1-IL-10), rAAV1-YFP, or saline were infused into left cerebral artery, respectively. Three weeks after, all animals were subjected to MCAO for 45min followed by reperfusion for 24h. ELISA and in situ hybridization using three DIG-labeled probes specific for rAAV1 backbone were performed to confirm the expression of IL-10. Neurologic dysfunction and infarct area were evaluated by neurological impaired use scores and TTC staining. Expressions of inflammatory mediators and endoplasmic reticulum stress proteins (ERP), including IL-1β, IL-10, TNF-α, MCP-1, MIP-1α, ICAM-1, TGF-β, VEGF, HO-1, ATF6 and CHOP, infarct boundary zone were measured by reverse transcription real time PCR. Results: Left cerebral artery of animals receiving rAAV1-IL-10 or rAAV1-YFP was stained positive for rAAV1 backbone. No positive staining was observed in animals perfused with PBS. The preexisting local IL-10 but not YFP decreased the neurological impaired use scores, infarct area and the number of injured neuronal cells. AAV1-IL-10 transduction decreased pro-inflammatory mediator TNF-α and increased intracellular protective protein HO-1. The increased expression of HO-1 was confirmed by Western blotting and immunohistochemical analysis. Other cytokines and ERP did not changed significantly. Conclusion: Preexisting IL-10 in susceptible cerebral arteries may decrease subsequent brain injury caused by ischemic/reperfusion through correcting pro-/anti-inflammatory balance and increasing intracellular protective proteins. Selective transduction of therapeutic gene in susceptible arteries during interventional stroke managements, such as thrombolysis and placing cerebrovascular stent, of the initial stroke is beneficial for recurrent stroke.

Neuroprotective genes activated in the liver in response to experimental stroke

Trefoil Factor 3 As an Endocrine Neuroprotective Factor from the Liver in Experimental Cerebral Ischemia/Reperfusion Injury

Hypoxia Inducible Factor-1α Attenuates Ischemic Brain Damage by Modulating Inflammatory Response and Glial Activity.

Regulatory T Cell is Critical for Interleukin-33-mediated Neuroprotection Against Stroke.

Neuroglobin expression in ischemic stroke.

Identification and analysis of key immunity-related genes in experimental ischemic stroke

Transgenic Overproduction of Omega-3 Polyunsaturated Fatty Acids Provides Neuroprotection and Enhances Endogenous Neurogenesis after Stroke

Omega-3 Fatty Acids Protect the Brain Against Ischemic Injury by Activating Nrf2 and Upregulating Heme Oxygenase 1

Fibronectin and neuroprotective effect of granulocyte colony-stimulating factor in focal cerebral ischemia.

VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia

Non-mitogenic fibroblast growth factor 1 protects against ischemic stroke by regulating microglia/macrophage polarization through Nrf2 and NF-κB pathways

Proinflammatory and Anti-inflammatory Genes in Stroke Pathogenesis

Neural Stem Cells Transfected with Leukemia Inhibitory Factor Promote Neuroprotection in a Rat Model of Cerebral Ischemia

Fibrinogen Deposition Promotes Neuroinflammation and Fibrin-Derived Γ377-395 Peptide Ameliorates Neurological Deficits after Ischemic Stroke

The role of microglial activation on ischemic stroke: modulation by fibroblast growth factors

Identification of brain endothelial cell-specific genes and pathways in ischemic stroke by integrated bioinformatical analysis

Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 Pathway

Abstract 142: Transgenic Overexpression of Krüppel-Like Factor 11 in Endothelium Ameliorates Ischemic Brain Injury

Abstract TMP5: Preexisting Interleukin-10 In Susceptible Cerebral Arteries May Decrease Subsequent Brain Injury Caused By Ischemic/reperfusion

Fibrinogen deposition promotes neuroinflammation and fibrin-derived γ 377-395 peptide ameliorates neurological deficits after ischemic stroke

Neuroglobin, a Novel Target for Endogenous Neuroprotection Against Stroke and Neurodegenerative Disorders.